Last reviewed · How we verify
Investigational COVID-19 Vaccine Lot B — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Investigational COVID-19 Vaccine Lot B (Investigational COVID-19 Vaccine Lot B) — ModernaTX, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Investigational COVID-19 Vaccine Lot B TARGET | Investigational COVID-19 Vaccine Lot B | ModernaTX, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Investigational COVID-19 Vaccine Lot B CI watch — RSS
- Investigational COVID-19 Vaccine Lot B CI watch — Atom
- Investigational COVID-19 Vaccine Lot B CI watch — JSON
- Investigational COVID-19 Vaccine Lot B alone — RSS
Cite this brief
Drug Landscape (2026). Investigational COVID-19 Vaccine Lot B — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-covid-19-vaccine-lot-b. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab